In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases.

导出原文传递

翻译打印收藏纠错

第一作者： Silvia,Giuliani

第一单位： Unit of Surgical Pathology, Santa Chiara Hospital, Largo Medaglie Oro 9, 38122, Trento, Italy.

作者： Silvia,Giuliani ^[1] ; Chiara Maura,Ciniselli ^[2] ; Elena,Leonardi ^[1] ; Enzo,Polla ^[1] ; Nicola,Decarli ^[1] ; Claudio,Luchini ^[1] ; Chiara,Cantaloni ^[1] ; Fabio,Gasperetti ^[3] ; Daniela,Cazzolli ^[3] ; Gabriella,Berlanda ^[4] ; Daniela,Bernardi ^[5] ; Marco,Pellegrini ^[5] ; Renza,Triolo ^[6] ; Antonella,Ferro ^[6] ; Paolo,Verderio ^[2] ; Mattia,Barbareschi ^[7]

作者单位： Unit of Surgical Pathology, Santa Chiara Hospital, Largo Medaglie Oro 9, 38122, Trento, Italy. ^[1] Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. ^[2] 1st Unit of Surgery, Santa Chiara Hospital, Trento, Italy. ^[3] 2nd Unit of Surgery, Santa Chiara Hospital, Trento, Italy. ^[4] Unit of Senology, Azienda Provinciale Servizi Sanitari, Trento, Italy. ^[5] Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. ^[6] Unit of Surgical Pathology, Santa Chiara Hospital, Largo Medaglie Oro 9, 38122, Trento, Italy. mattia.barbareschi@apss.tn.it. ^[7] Trentino Biobank, Unit of Surgical Pathology, Santa Chiara Hospital, Trento, Italy. mattia.barbareschi@apss.tn.it. ^[8]

关键词 Breast carcinoma FISH HER2 Immunohistochemistry